Canada-based Willow Biosciences (CSE: WLLW) was recently featured
in a video by InvestmentPitch Media detailing how the company utilizes its
proprietary biosynthetic processes to deliver high yields of ultra-pure,
low-cost cannabinoids. An article further discussing the company reads, “The video
(http://ibn.fm/gRZL3)
highlights a recent joint development agreement between Alberta, Canada-based
Willow Biosciences and Delaware-headquartered Noramco that will build on
Willow’s experience in developing manufacturing processes for active
pharmaceutical ingredients (‘APIs’) that treat conditions such as cancer, pain
and central nervous system disorders, as well as Noramco’s experience in
producing high-quality, synthetic cannabinoid APIs for the pharmaceutical and
health care industry. . . . Under the agreement, Willow will focus on
developing ultra-pure CBD with its pioneering biosynthetic technology,
bypassing the costs and waste associated with plant cultivation for a single
cannabinoid by optimizing yeast cultivation processes, while Noramco will be
responsible for the scale-up, regulatory applications, marketing and
distribution of the companies’ products. Their work has the potential to open
new and larger markets for CBD and related compounds, as well as providing
low-cost solutions to pharmaceutical partners.”
To view the full article, visit http://ibn.fm/PHv4p
About Willow Biosciences Inc.
Headquartered in Calgary, Canada, Willow and its team of
scientists are leaders in the field of biosynthetic production of high-value,
plant-derived compounds. Willow has applied its integrated suite of
technologies to develop manufacturing processes for numerous active
pharmaceutical ingredients with various therapeutic benefits, including cancer
treatment, pain management and CNS disorders. In the cannabinoid field, Willow
owns proprietary, yeast-based lab strains that produce CBD,
tetrahydrocannabinol (THC) and cannabigerol (CBG), as well as certain minor and
novel cannabinoids. For more information, visit the company’s website at www.WillowBio.com.
NOTE TO INVESTORS: The latest news and updates
relating to WLLW are available in the company’s newsroom at http://ibn.fm/WLLW
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer excellent
growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment